4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride

C28H45ClN4O — CID 146071835

IUPAC4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride
SMILESCl.O=C(CCC[C@H]1NC[C@@H]2C[C@H]1CN(Cc1ccccc1)C2)N1CCN(C2CCCCC2)CC1
InChIInChI=1S/C28H44N4O.ClH/c33-28(32-16-14-31(15-17-32)26-10-5-2-6-11-26)13-7-12-27-25-18-24(19-29-27)21-30(22-25)20-23-8-3-1-4-9-23;/h1,3-4,8-9,24-27,29H,2,5-7,10-22H2;1H/t24-,25-,27+;/m0./s1
InChIKeyPCVXPEJRESOCPQ-QXVHYAKRSA-N
MW489.15 g/mol
LogP4.17
Rot. Bonds7

About 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride

4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride (PubChem CID 146071835) has the molecular formula C28H45ClN4O and a molecular weight of 489.15 g/mol. Its IUPAC name is 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride.

Molecular Properties

Compound Name4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride
PubChem CID146071835
Molecular FormulaC28H45ClN4O
Molecular Weight489.15 g/mol
Exact Mass488.33
IUPAC Name4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride
SMILESCl.O=C(CCC[C@H]1NC[C@@H]2C[C@H]1CN(Cc1ccccc1)C2)N1CCN(C2CCCCC2)CC1
InChIInChI=1S/C28H44N4O.ClH/c33-28(32-16-14-31(15-17-32)26-10-5-2-6-11-26)13-7-12-27-25-18-24(19-29-27)21-30(22-25)20-23-8-3-1-4-9-23;/h1,3-4,8-9,24-27,29H,2,5-7,10-22H2;1H/t24-,25-,27+;/m0./s1
InChIKeyPCVXPEJRESOCPQ-QXVHYAKRSA-N
XLogP4.17
TPSA38.82 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500489.15
LogP ≤ 54.17
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride?
The IUPAC name of 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride (CID 146071835) is 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride.
What is the SMILES notation for 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride?
The canonical SMILES for 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride is Cl.O=C(CCC[C@H]1NC[C@@H]2C[C@H]1CN(Cc1ccccc1)C2)N1CCN(C2CCCCC2)CC1.
What is the InChIKey of 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride?
The InChIKey is PCVXPEJRESOCPQ-QXVHYAKRSA-N. The full InChI is InChI=1S/C28H44N4O.ClH/c33-28(32-16-14-31(15-17-32)26-10-5-2-6-11-26)13-7-12-27-25-18-24(19-29-27)21-30(22-25)20-23-8-3-1-4-9-23;/h1,3-4,8-9,24-27,29H,2,5-7,10-22H2;1H/t24-,25-,27+;/m0./s1.
What are the key properties of 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride?
4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride has a molecular weight of 489.15 g/mol, XLogP of 4.17, 7 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(1S,2R,5S)-7-benzyl-3,7-diazabicyclo[3.3.1]nonan-2-yl]-1-(4-cyclohexylpiperazin-1-yl)butan-1-one;hydrochloride is sourced from PubChem (CID 146071835), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).